Speciality: All Speciality
Description:
A warm welcome to all the medical professionals in this interesting session on the benefits of influenza vaccination in high risk populations of diabetes and COPD patients. In this webinar, Dr. Marco Goeijenbier has shared the insights on the benefits of influenza vaccination in high risk populations.
Influenza is responsible for multiple deaths and about 20 to 30% of the deaths occurring annually are observed in children depicting the poor condition of controlling influenza in children. The virus is present globally but is not that powerful to create an epidemic.
Influenza is a contagious infection in nature causing high fever, body aches, cough, and other symptoms. Basically the children suffer for less than a week with the flu, but in cases of serious illness, they may need to be admitted to the hospital.
Among people with diabetes and chronic lung disease like COPD influenza causes severe impacts and flu vaccination has been shown to be associated with reduced hospitalizations from a worsening of their chronic condition. Flu vaccinations can shorten the length of hospital stay due to flu, reduce the risk of ICU admission from flu and also helps in reducing the risk of death from flu.
Therefore, get an overall knowledge regarding the benefits of influenza vaccination in high risk populations of diabetes and COPD patients.
See More Webinars @ Hidoc Webinars
See More Webinars @ Hidoc Webinars
1.
Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.
2.
Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.
3.
Long-term study links chronic conditions in midlife to higher cancer risk and mortality
4.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
5.
When does a melanoma metastasize? Implications for management
1.
Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results
2.
The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies
3.
Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025
4.
Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked
5.
Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation